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The future of NMR-based metabolomics
John L Markley1, Rafael Bru¨schweiler2,3, Arthur S Edison4,
Hamid R Eghbalnia1, Robert Powers5, Daniel Raftery6 and
David S Wishart7,8
The two leading analytical approaches to metabolomics are
mass spectrometry (MS) and nuclear magnetic resonance
(NMR) spectroscopy. Although currently overshadowed by MS
in terms of numbers of compounds resolved, NMR
spectroscopy offers advantages both on its own and coupled
with MS. NMR data are highly reproducible and quantitative
over a wide dynamic range and are unmatched for determining
structures of unknowns. NMR is adept at tracing metabolic
pathways and fluxes using isotope labels. Moreover, NMR is
non-destructive and can be utilized in vivo. NMR results have a
proven track record of translating in vitro findings to in vivo
clinical applications.
Addresses
1 Biochemistry Department, University of Wisconsin-Madison,
433 Babcock Drive, Madison, WI 53706, USA
2 Department of Chemistry & Biochemistry, The Ohio State University,
151 W. Woodruff Ave., Columbus, OH 43210, USA
3 Department of Biological Chemistry & Pharmacology, The Ohio State
University, 151 W. Woodruff Ave., Columbus, OH 43210, USA
4 Department of Genetics and Biochemistry, Institute of Bioinformatics
and Complex Carbohydrate Center, University of Georgia,
315 Riverbend Rd, Athens, GA 30602, USA
5 Department of Chemistry, University of Nebraska-Lincoln,
722 Hamilton Hall, Lincoln, NE 68588, USA
6 Department of Anesthesiology & Pain Medicine, 850 Republican St,
University of Washington, Seattle, WA 98109, USA
7 Department of Biological Sciences, University of Alberta, Edmonton,
AB, Canada T6G 2E8
8 Department of Computing Science, University of Alberta, Edmonton,
AB, Canada T6G 2E8
Corresponding author: Markley, John L (jmarkley@wisc.edu)
Current Opinion in Biotechnology 2017, 43:34–40
This review comes from a themed issue on Analytical biotechnology
Edited by Jurre J Kamphorst and Ian A Lewis
For a complete overview see the Issue and the Editorial
Available online 28th August 2016
http://dx.doi.org/10.1016/j.copbio.2016.08.001
0958-1669/# 2016 The Author(s). Published by Elsevier Ltd. This is an
open access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).
Introduction
The metabolic state of an organism depends on its
genome, transcriptome, proteome, epigenome, micro-
biome, and exposome (environment). Thus, metabolo-
mics, the study of small molecules (<1500 Da) in living
systems, provides information with a high potential for
accurately describing the physiological state of an organ-
ism. The two most successful approaches to determining
the metabolic state of an organism have been mass
spectrometry (MS) and nuclear magnetic resonance
(NMR) spectroscopy. Several years ago, the number of
publications utilizing the two approaches were compara-
ble; more recently, however, MS-based metabolomics has
clearly overtaken NMR-based metabolomics. This state
of affairs prompted the organization of a workshop to
review the current state of NMR-based metabolomics, to
assess its strengths and weaknesses, and to envision its
future potential. As reported here, this workshop (‘NMR-
Based Metabolomics,’ held in the Discovery Building,
Morgridge Institute for Research, Madison, Wisconsin,
USA, on June 10, 2016) highlighted a number of benefits
of NMR-based metabolomics that appear to be currently
underappreciated. MS and NMR offer different
strengths, which can be used synergistically. The work-
shop stressed the need for more extensive small molecule
databases and improved standards at each step of a
metabolomics study.
The metabolome
The two major fields of chemical research on biological
small molecules, metabolomics and natural product dis-
covery, have the similar goals of identifying and charac-
terizing small molecules, either in their isolated active
state (natural product chemistry) or as mixtures (meta-
bolomics) [1]. The number of small molecules of impor-
tance to humans is far greater than those currently
represented on metabolic charts, with the excess consti-
tuting current ‘metabolic dark matter’ (Figure 1). The
swapping of metabolites between pathways in humans
and those of organisms in the human microbiome
increases the network of relevant reactions by a stagger-
ing amount. The HMDB [2] lists 42 000 metabolites and
the number of lipid variants is on the order of 100 000;
thus, a lower limit of expected endogenous and exoge-
nous human metabolites is around 150 000, but the actual
number of metabolites could be much higher. Of this vast
number of metabolites, only 1500 may be identified from
global profiling, 200–500 from targeted profiling, and far
fewer are routinely subjected to quantitative analysis.
NMR and its advantages
Despite its lower sensitivity, NMR spectroscopy offers
many unparalleled advantages over MS [3,4]. NMR
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offers a window into observing and rigorously quantifying
all of the more abundant compounds present in biological
fluids, cell extracts, and tissues without the need for
elaborate sample preparation or fractionation. NMR
offers advantages for compounds that are difficult to
ionize or require derivatization for MS. NMR allows
the identification of compounds with identical masses,
including those with different isotopomer distributions.
NMR is the mainstay for determining structures of un-
known compounds. Through the use of stable isotope
labels, NMR can be used to elucidate the dynamics and
mechanisms of metabolite transformations and to explore
the compartmentalization of metabolic pathways. NMR
has advantages in drug screening [5]. Finally, site-specific
NMR imaging and spectroscopy offer approaches for
metabolic studies in living organisms.
Strategies for the identification of metabolites in complex
mixtures from NMR data have been reviewed recently
[6]. The most important nuclei in biomolecular NMR
studies are 1H (proton), 13C, 15N, and 31P. Of these, 1H is
the most sensitive followed by 31P; both are present at
near 100% natural abundance. 31P NMR is useful for
studies of cellular energy states in vivo and ex vivo, but a
limitation is that the 31P signals from most phosphorylat-
ed compounds overlap. One-dimensional (1D) 1H NMR
is the most widely used NMR approach in metabolomics.
Signals are either binned and then analyzed or fitted to
patterns of signals corresponding to the metabolites
expected to be present in the mixture. The latter ap-
proach can be problematic in that many 1H signals overlap
in ways that offer alternative fitting solutions, a problem
that can be overcome by standardizing the analysis in
terms of biofluid, solution conditions, data collection
protocol, and by employing probabilistic fitting (Bayesil)
[7]. 13C NMR signals cover a 200 ppm range compared
with 10 ppm for 1H and as a consequence are better
resolved; however, the low sensitivity of 13C (less by a
factor of 8 or more) is compounded by its low natural
abundance (1.1%). Two dimensional (2D) NMR methods
offer improved approaches for unambiguous identifica-
tion of metabolites in mixtures. These 2D methods
include 1H-1H COSY (correlated spectroscopy), 1H–1H
TOCSY (total correlation spectroscopy), and 1H–13C
HSQC (heteronuclear single-quantum correlation). A
widely used software package (rNMR) matches regions
of interest in spectra of standards to those in experimental
mixtures for compound identifications [8]. Software is
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available for automating metabolite identification from
combined TOCSY and HSQC data [9,10]. By setting
tolerances for the matching of 1H and 13C signals, one can
maximize compound identification while minimizing
false positives [11]. This approach has been extended
to a calculated confidence level for compound identifica-
tions from NMR data [12]. Another approach for con-
necting signals from individual compounds in mixtures is
based on searching for statistical correlations among the
intensities of NMR signals from various samples [13].
Nuclei present at low natural abundance 2H (deuteron),
13C, and 15N serve as ideal metabolic tracers [14].
Need for standards in NMR metabolomics
Standard NMR spectra and associated information on
small biological molecules are available from freely-
accessible databases, including HMDB [2], BMRB
[15], TOCCATA [9], and COLMAR [10], but they still
cover only a fraction of relevant compounds. A repository
has been established for results of metabolomics studies
from the NIH Common Fund Centers [16]. The Coor-
dination of Standards in Metabolomics (COSMOS) Ini-
tiative is developing a robust data infrastructure and new
data exchange standards (http://nmrml.org) for metabo-
lomics data and metadata to support workflows metabo-
lomics applications [17]. One of the COSMOS projects
is a website (http://metabolomexchange.org) that feder-
ates data available from the leading metabolomics data
repositories. Best practices and standards have been
published for metabolic phenotyping of biological fluids
[18,19]. An open-source platform for complete NMR
metabolomics data handling (MVAPACK) has been de-
veloped as a step toward establishing best practices for
the analysis of metabolic fingerprinting data [20].
Sample preparation
Certain biofluids, for example, cerebrospinal fluid, re-
quire little or no preparation for NMR. Others, such as
plasma contain proteins and lipids that interfere with
NMR spectral quality. Treatment with methanol at
solvent-to-serum ratio of 2:1 (v/v) has been shown to
remove lipoproteins and minimize the loss of metabo-
lites [21] enabling the detection of about 67 different
compounds [22]. Another promising protocol utilizes
the removal of protein by added silica nanoparticles
[23].
Tagging
An approach for compounds with overlapping 1H signals
or present at lower concentration is to tag them with an
NMR-active label. Nitrogen-15 with attached hydrogen
is an attractive tag because 2D 1H–15N signals can be
acquired at high sensitivity without interference from
signals from unlabeled compounds owing to the low
natural abundance of 15N [24,25]. Such tags also provide
a permanent positive charge for MS analysis.
Combining NMR and MS
As reviewed recently [26], advances in NMR-based and
MS-based metabolomics, including the combination of
the two approaches, promise to greatly improve the
identification and quantitation of compounds in mixtures.
One example is the simultaneous analysis of DI-ESI-MS
and 1D 1H NMR spectral data to yield accurate mass
measurements and class separation scores [27]. Other
approaches filter data from one approach against the other
to increase the number of compounds confidently identi-
fied [28,29]. Another method identifies compounds by
exploiting the principle that abundance/intensity ratios
are relatively constant for the same metabolite in differ-
ent samples [30]. Combined NMR and MS has advan-
tages for isotope tracing experiments and metabolic flux
analysis. MS generally quantifies isotopic labeling distri-
butions but even with MS/MS often does not give the
specific labeling position, which is available from NMR.
Quantification
If 1D 1H NMR peaks from a compound are well resolved
with acceptable signal-to-noise, their intensities correlate
linearly with its relative concentration. To determine
absolute concentrations, one adds a standard of known
concentration. The cross peak intensities of the same 2D
1H–13C HSQC spectrum, however, do not correlate line-
arly with concentration. One can collect spectra of mix-
tures with known concentrations bracketing those of the
unknowns and use these to determine factors that trans-
late peak intensity to concentration [31]. Peak intensities
in 2D 1H–13C HSQC spectra can also be converted to
concentration from the slopes generated by spectra uti-
lizing different replicates of the pulse sequence module
and the linear extrapolation back to zero time of the peak
intensities following the delays from one and two mod-
ules yields the ‘HSQC0 spectrum’ whose peak intensities
are proportional to concentration [32]. Spectral overlaps
can be accounted for by methods such as FMLR (fast
maximum-likelihood reconstruction) [33]. A new experi-
ment (1H–13C QUIPU HSQC) aims to quantify in one
map a complex mixture composed of low concentrated
metabolites [34]. Another approach, one that requires full
13C labeling, achieves quantification through the collec-
tion of 13C–13C CT-TOCSY spectra and the application
of analytical approximations based on the known carbon-
backbone topologies [35].
Applications of metabolomics
Applications of metabolomics include disease diagnosis,
monitoring the effects of medical interventions including
drugs, detection of adulteration of food, and analysis of
biochemical pathways and their perturbations resulting
from mutations, aging, diet, exercise, or life style. A recent
study showed how ex vivo 1D 1H NMR spectroscopy can
be used for the simultaneous identification and quantifi-
cation of co-enzymes that report on cellular function
[36]. Another study used this approach to investigate
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alterations in the energy/redox-metabolome in dopami-
nergic cells exposed to environmental/mitochondrial tox-
ins [37]. Studies of the metabolomics of model organisms
are both timely and important for understanding of their
different biology [38]. Protocols have been described for
studies of the metabolomics of bacteria [39] and plants
[40]. Metabolomics, along with activity-guided fraction-
ation followed by structural analysis, constitutes a power-
ful approach for identifying biologically active compounds
for studies in chemical ecology [41]. Metabolomics is
used regularly in drug discovery programs to uncover the
efficacy, specificity, or toxicity of lead compounds [42].
Metabolomics can provide information on the in vivo
mechanism of action and to eliminate compounds likely
to cause problems with side effects [43]. Recent studies
have utilized metabolomics to search for biomarkers for
colon cancer [44] and multiple sclerosis [45].
Future technology
All technologies that increase NMR sensitivity are of
extreme importance as are improvements in sample
preparation [46]. Approaches to high sensitivity include
NMR spectrometers with ultra-high-field magnets oper-
ating at 1H resonance frequencies of 1.2 GHz or higher.
The first such systems are scheduled for delivery in
2017. Small high-temperature superconducting coils
can maximize the signal per sample mass: a 13C-opti-
mized 1.5-mm high temperature superconducting NMR
probe has enabled novel 13C NMR studies of natural
products [47], and this has been followed up with a
1H–13C dual-optimized NMR probe based on double-
tuned high temperature superconducting resonators
[48]. These probes take advantage of the excellent peak
dispersion of 13C spectra [49], which can be augmented
by further 2D 13C–13C experiments, such as INADE-
QUATE [50].
Hyperpolarization offers an approach for enhanced sen-
sitivity with even higher potential. The underlying phys-
ics utilizes the magnetic moment of the unpaired
electron, which is roughly 2800 times that of 13C and
6900 times that of 15N, to polarize nuclear spins. First
demonstrated by Golman and coworkers [51], studies
utilizing hyperpolarized 13C to increase sensitivity are
becoming routine. An exciting advance is the discovery
[52] of an efficient and inexpensive method for hyper-
polarizing 15N spins at room temperature. Enhancements
are on the order of >10 000 enabling the detection of
NMR signals for over an hour [52]. It may become
possible to use this approach to tag a range of compounds
for metabolomics studies in vivo.
Conclusions
The workshop demonstrated that NMR-based metabo-
lomics promises to continue to play an important role in
the studies of complex mixtures of small biological mole-
cules, their metabolic networks, and their interactions
with biomacromolecules. Although the development of
new and better methods continues to be an integral part,
the field needs to focus on developing standardized,
enlarged, and integrated databases of NMR data on small
molecules as well as archives representing the NMR
metabolic fingerprints of standard biological fluids and
tissue extracts from humans and model organisms. Stan-
dardization of best practices for sample preparation, data
collection and analysis should enhance the reproducibili-
ty of results within the metabolomics community, while
at the same time avoiding the risk of adhering to methods
and protocols that are suboptimal in a field that is very
much in flux. In order to overcome skepticism in omics
[53], it will be advisable for metabolomics to build the
ideas of reproducibility and data sharing into every tool
and database. Future work is expected to build upon core
strengths of NMR spectroscopy, which includes its ver-
satility and specificity in the form of 1D and higher
dimensional spectra, its reproducibility, its quantitative
ability, its capability for following chemical reactions and
flux, its ability to identify compounds and deduce struc-
tures of unknowns, and its growing potential for collecting
metabolomics data in vivo.
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